Tracing cell fates in human colorectal tumors from somatic microsatellite mutations: Evidence of adenomas with stem cell architecture

American Journal of Pathology

Volumn 153, Issue 4, 1998, Pages 1189-1200

  Tsao, Jen Lan ^a   Zhang, Jingsong ^a   Salovaara, Reijo ^b   Li, Zhi Hua ^a   Järvinen, Heikki J ^c   Mecklin, Jukka Pekka ^d   Aaltonen, Lauri A ^b   Shibata, Darryl ^a,e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^e Box 736 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL PROLIFERATION; COLORECTAL TUMOR; COMPUTER SIMULATION; CONTROLLED STUDY; CYTOARCHITECTURE; GENE LOCUS; HUMAN; HUMAN CELL; INTESTINE MUCOSA; MITOSIS; MUTATION RATE; PHYLOGENY; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 0031667785     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65663-5     Document Type: Article

References (42)

1. Strauss M, Lukas J, Bartek J: Unrestricted cell cycling and cancer. Nature Med 1995, 1:1245-1246
2. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170
3. Koretz RL: Malignant polyps: are they sheep in wolves' clothing? Ann Internal Med 1993, 118:63-68
4. Stryker SJ, Wolff BG, Gulp CE, Libbe SD, Ilstrup DM, MacCarty RL: Natural history of untreated colonic polyps. Gastroenterology 1987, 93:1009-1013
5. Otchy DP, Ransohoff DF, Wolff BG, Waver A, Ilstrup D, Carlson H, Rademacher D: Metachronous colon cancer in persons who have had a large adenomatous polyp. Am J Gastroenterol 1996, 91:448-454
6. Nowell PC: The clonal evolution of tumor cell populations. Science 1976, 194:23-28
7. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991, 51:3075-3079
8. + tumor cells. Cell 1993, 75:1227-1236
9. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M: Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet 1994, 6:273-281
10. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M: Mutator phenotypes human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 1994, 91:6319-6323
11. Shibata D, Navidi W, Salovaara R, Li ZH, Aaltonen LA: Somatic microsatellite mutations as molecular tumor clocks. Nature Med 1996, 2:676-681
12. Tsao JL, Davis SD, Baker SM, Liskay RM, Shibata D: Intestinal stem cell divisions and genetic diversity: a computer and experimental analysis. Am J Pathol 1997, 51:573-579
13. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 1993, 260:816-819
14. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature 1997, 386:623-627
15. Rotten CS, Loeffler M: Stem cells: attributes, cycles, spirals, pitfalls, and uncertainties. Lessons for and from the crypt. Development 1990, 110:1001-1020
16. Marsischky GT, Filosi N, Kane MF, Kolodner R: Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dev 1996, 10:407-420
17. Steel GG: Growth Kinetics of Tumors. Oxford, Clarendon, 1977
18. Steel GG: Cell loss as a factor in the growth rate of human tumors. Eur J Cancer 1967, 3:381-387
19. Streisinger G, Okada Y, Emrich J, Newton J, Tsugita A, Terzaghi E, Inouye M: Frameshift mutations and the genetic code. Cold Spring Harbor Symp Quant Biol 1966, 31:77-84
20. Strand M, Prolla TA, Liskay RM, Petes TD: Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993, 365:274-276
21. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984, 133:1710-1715
22. Shibata D: Molecular tumor clocks and dynamic phenotype. Am J Pathol 1997, 151:643-646
23. Sankila R, Aaltonen LA, Järvinen HJ, Mecklin JP: Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996, 110:682-687
24. Lynch HT, Lanspa S, Smyrk T, Boman B, Watson P, Lynch J: Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): genetics, pathology, natural history, and cancer control, part I. Cancer Genet Cytogenet 1991, 53:143-160
25. Jan YN, Jan LY: Asymmetrical cell division. Nature 1998, 392:775-778
26. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S: Telomerase activity associated with acduisition of malignancy in human colorectal cancer. Cancer Res 1995, 55:2533-2536
27. Kim SH, Roth KA, Moser AR, Gordon JI: Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J Cell Biol 1993, 123:877-893
28. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B: Topological control of p21 (Waf1/Cip1) expression in normal and neoplastic tissues. Cancer Res 1995, 55:2910-2919
29. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW: Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol 1996, 149:381-387
30. Shibata D, Schaeffer J, Li ZH, Capella G, Perucho M: Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not adenocarcinomas. J Natl Cancer Inst 1993, 85:1058-1063
31. Borland CR, Sato J, Appelman HD, Bresalier RS, Feinberg AP: Microallelotyping defines the sequence and tempo of allelic losses at tumor suppressor gene loci during colorectal cancer progression. Nature Med 1995, 1:902-909
32. Novelli MR, Williamson JA, Tomlinson IPM, Elia G, Hodgson SV, Talbot IC, Bodmer WF, Wright NA: Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science 1996, 272:1187-1190
33. Moser AR, Dove WF, Roth KA, Gordon JI: The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial differentiation and interaction with a modifier system. J Cell Biol 1992, 116:1517-1526
34. Gould KA, Dove WF: Localized gene action controlling intestinal neoplasia in mice. Proc Natl Acad Sci USA 1997, 94:5848-5853
35. Perzin KH, Fenoglio CM, Pascal RR: Neoplastic diseases of the small and large intestine. Principles and Practice of Surgical Pathology. Edited by Silverberg SS. New York, John Wiley and Sons, 1983, pp 915-918
36. Bjerknes M: Expansion of mutant stem cell populations in the human colon. J Theor Biol 1996, 178:381-385
37. Niv Y, Fraser GM: Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 1994, 107:854-857
38. Thorson AG, Lynch HT, Smyrk TC: Rectal cancer in FAP patient after sulindac. Lancet 1994, 343:180
39. Mackillop WJ, Ciampi A, Till JE, Buick RN: A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J Natl Cancer Inst 1983, 70:9-16
40. Cairns J: Mutation selection and the natural history of cancer. Nature 1975, 255:197-200
41. Nyström-Lahti M, Wu Y, Moisio AL, Hofstra RM, Osinga J, Mecklin JP, Järvinen HJ, Leisti J, Buys CHCM, de la Chapelle A, Peltomäki P: DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996, 5:763-769
42. Nyström-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, Järvinen HJ, Mecklin JP, Kinzler KW, Vogelstein B, de la Chapelle A, Peltomäki P: Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nature Med 1995, 1:1203-1206